(Q42526517)

1 November 2017

title

p63 expression in normal skin and usual cutaneous carcinomas (English)

1 reference

1 November 2017

3

1 reference

1 November 2017

4

1 reference

1 November 2017

1

Jorge S Reis-Filho

1 reference

1 November 2017

Beatriz Torio

2

1 reference

1 November 2017

publication date

1 October 2002

1 reference

Journal of Cutaneous Pathology

1 November 2017

published in

1 reference

1 November 2017

volume

29

1 reference

1 November 2017

issue

9

1 reference

1 November 2017

page(s)

517-523

1 reference

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Association of p63 with proliferative potential in normal and neoplastic human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

p63 and p73 transactivate differentiation gene promoters in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

p63 identifies keratinocyte stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Why classify basal cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Maspin expression in myoepithelial tumors of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

p63 is a prostate basal cell marker and is required for prostate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

AIS is an oncogene amplified in squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

p63 expression during normal cutaneous wound healing in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2002.290902.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-0560.2002.290902.X

1 reference

1 November 2017

1 reference